← All trials
NCT07283770
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 9, 2025
- Primary completion
- Nov 19, 2026
- Completion date
- Nov 19, 2026
- First posted
- Dec 16, 2025
- Last posted
- Dec 29, 2025
- Enrollment
- 128
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- VertexLead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.